Literature DB >> 1681823

Oxaprotiline enantiomers stimulate ACTH and corticosterone secretion in the rat.

E Przegaliński1, B Budziszewska, A Grochmal.   

Abstract

The effect of oxaprotiline (OXA) enantiomers--of which (+)-OXA inhibits noradrenaline (NA) uptake, whereas (-)-OXA does not--on the secretion of adrenocorticotropin hormone (ACTH) and corticosterone was studied in rats. Both enantiomers dose-dependently and with a similar potency increased the plasma level of ACTH and corticosterone, the effect of (-)-OXA on corticosterone being of a longer duration. The stimulation of ACTH secretion and the inability of (+)- and (-)-OXA to increase the plasma corticosterone concentration in animals pretreated with dexamethasone indicate that secretion of the latter hormone results from the action of the enantiomers at a level superior to the adrenal cortex, i.e. the hypothalamus/pituitary. The corticosterone response to (+)- or (-)-OXA was not modified in rats with a selective lesion of NA nerve endings induced by the neurotoxin DSP-4, nor was it affected by the selective alpha 1-antagonist prazosin, the selective alpha 2-antagonist yohimbine, the mixed alpha 1/alpha 2-antagonist phentolamine, the selective dopamine (D2) receptor antagonist sulpiride and the non-selective 5-hydroxytryptamine (5-HT) receptor antagonist metergoline. These results indicate that neither the NA system nor D2 and 5-HT receptors are involved in the hormonal response to the OXA enantiomers. Although the (+)- and (-)-OXA-induced stimulation of corticosterone secretion was not antagonized by diazepam, ipsapirone, naloxone, or propranolol, it cannot be excluded that both these enantiomers act as non-specific stressors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681823     DOI: 10.1007/bf01244946

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  34 in total

Review 1.  Neurotransmitter regulation of anterior pituitary hormones.

Authors:  J Tuomisto; P Männistö
Journal:  Pharmacol Rev       Date:  1985-09       Impact factor: 25.468

2.  Single treatments with the antidepressant oxaprotiline and its (+) and (-) enantiomers increase behavioural responses to dopaminergic stimulation in the rat.

Authors:  A Delini-Stula; E Mogilnicka
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  Adrenergic control mechanism for ACTH secretion in man.

Authors:  Y Nakai; H Imura; T Yoshimi; S Matsukura
Journal:  Acta Endocrinol (Copenh)       Date:  1973-10

4.  Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.

Authors:  J C Buckingham; T A Cooper
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

5.  Stress-induced renin and corticosterone secretion is mediated by catecholaminergic nerve terminals in the hypothalamic paraventricular nucleus.

Authors:  K D Richardson Morton; L D Van de Kar; M S Brownfield; S A Lorens; T C Napier; J H Urban
Journal:  Neuroendocrinology       Date:  1990-03       Impact factor: 4.914

6.  Relationships between plasma corticosteroids and benzodiazepines in stress.

Authors:  G Le Fur; F Guilloux; N Mitrani; J Mizoule; A Uzan
Journal:  J Pharmacol Exp Ther       Date:  1979-11       Impact factor: 4.030

7.  Dose-dependent growth hormone, prolactin and cortisol stimulation after i.v. administration of desimipramine in human subjects.

Authors:  G Laakmann; H W Schoen; D Blaschke; M Wittmann
Journal:  Psychoneuroendocrinology       Date:  1985       Impact factor: 4.905

Review 8.  Neurobiochemical aspects of maprotiline (Ludiomil) action.

Authors:  P A Baumann; L Maître
Journal:  J Int Med Res       Date:  1979       Impact factor: 1.671

9.  Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptake.

Authors:  S A Checkley; C Thompson; S Burton; C Franey; J Arendt
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.

Authors:  G Jonsson; H Hallman; F Ponzio; S Ross
Journal:  Eur J Pharmacol       Date:  1981-06-19       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.